Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 111685)

1.

Studies on the disposition of diosgenin in rats, dogs, monkeys and man.

Cayen MN, Ferdinandi ES, Greselin E, Dvornik D.

Atherosclerosis. 1979 May;33(1):71-87.

PMID:
111685
2.

Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.

Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.

Arzneimittelforschung. 1998 Oct;48(10):995-1006.

PMID:
9825117
4.

In vivo and in vitro studies of hypocholesterolemic effects of diosgenin in rats.

Juarez-Oropeza MA, Diaz-Zagoya JC, Rabinowitz JL.

Int J Biochem. 1987;19(8):679-83.

PMID:
3622900
6.

Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.

Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.

Arzneimittelforschung. 1993 Oct;43(10):1084-94.

PMID:
8267675
7.
8.

Effect of diosgenin on lipid metabolism in rats.

Cayen MN, Dvornik D.

J Lipid Res. 1979 Feb;20(2):162-74.

9.

The metabolic disposition of etodolac in rats, dogs, and man.

Cayen MN, Kraml M, Ferdinandi ES, Greselin E, Dvornik D.

Drug Metab Rev. 1981;12(2):339-62.

PMID:
6461537
10.

Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man.

Ahr HJ, Boberg M, Krause HP, Maul W, Müller FO, Ploschke HJ, Weber H, Wünsche C.

Arzneimittelforschung. 1989 Oct;39(10):1254-60.

PMID:
2610717
12.

Absorption, distribution, metabolism, and excretion of [¹⁴C]GDC-0449 (vismodegib), an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening.

Yue Q, Chen YH, Mulder T, Deese A, Takahashi R, Rudewicz PJ, Reynolds M, Solon E, Hop CE, Wong H, Khojasteh SC.

Drug Metab Dispos. 2011 Jun;39(6):952-65. doi: 10.1124/dmd.110.037374. Epub 2011 Mar 1.

13.

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.

Maurer G, Schreier E, Delaborde S, Nufer R, Shukla AP.

Eur J Drug Metab Pharmacokinet. 1983;8(1):51-62.

PMID:
6861794
14.

Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.

Tachibana M, Tanaka M, Mitsugi K, Jin Y, Takaichi M, Okazaki O.

Arzneimittelforschung. 2004;54(12):898-905.

PMID:
15646375
15.

Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.

Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S.

Arzneimittelforschung. 1997 Jan;47(1):29-35.

PMID:
9037440
17.

Disposition of sucrose octa-isobutyrate in rats, dogs and monkeys.

Noker PE, Kalin JR, McCarthy DJ, el Dareer SM, Chappel CI.

Food Chem Toxicol. 1986 Dec;24(12):1287-93.

PMID:
3100405
18.

Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.

Uchida T, Nakamura E, Usui T, Imasaki H, Kawakami R, Watanabe T, Higuchi S.

Xenobiotica. 1994 Dec;24(12):1223-36.

PMID:
7771109
19.

Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.

Bechtel WD, Mierau J, Richter I, Stiasni M.

Arzneimittelforschung. 1986 Mar;36(3A):568-74.

PMID:
3718579
20.

Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.

Vickers S, Duncan CA, Slaughter DE, Arison BH, Greber T, Olah TV, Vyas KP.

Drug Metab Dispos. 1998 May;26(5):388-95.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk